You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment

Authors

  • Yongling Ning Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China Oncology Institute, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Jun Ding Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China Oncology Institute, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Xiao Sun Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Yewen Xie Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Mingming Su Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Chenglong Ma Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China Department of Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, China PubMed articlesGoogle scholar articles
  • Jie Pan Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Jie Chen Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Hua Jiang Oncology Institute, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Chunjian Qi Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China Oncology Institute, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chunjian Qi; qichunjian{at}njmu.edu.cn
View Full Text

Citation

Ning Y, Ding J, Sun X, et al
HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment
Journal for ImmunoTherapy of Cancer 2020;8:e000529. doi: 10.1136/jitc-2020-000529

Publication history

  • Accepted May 14, 2020
  • First published June 17, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.